Jennifer Connelly
Endocrinology, Diabetes & Metabolism · Long Beach, CANPI 1710026935
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $265,276 of the $295,868 with a category attached, or 89.7%. Lilly USA, LLC accounts for 89.5% of it on its own, with 21 other manufacturers making up the rest. Among endocrinology, diabetes & metabolism clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 645 payments — averaging $458.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$265K
- Dexcom, Inc.$21K
- Johnson & Johnson$8K
- Insulet Corporation$381
- Novo Nordisk$249
- AstraZeneca$238
- plus $1K from 16 others
What the payments were for
- Consulting fees$3,6481%
- Speaking & faculty fees$265,27690%
- Travel & lodging$17,6976%
- Food & beverage$9,2343%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 482 | $264,886 |
| Dexcom, Inc. | 24 | $20,634 |
| Johnson & Johnson | 25 | $8,077 |
| Insulet Corporation | 24 | $381 |
| Novo Nordisk | 15 | $249 |
| AstraZeneca | 8 | $238 |
| AbbVie | 7 | $223 |
| Amgen | 5 | $215 |
| Boehringer Ingelheim | 11 | $179 |
| Abbott | 8 | $147 |
| Sanofi-aventis U.S. LLC | 9 | $127 |
| Radius Health, Inc. | 3 | $86 |
| Medtronic(2 entities) | 5 | $81 |
| Merck | 4 | $75 |
| Tandem Diabetes Care, Inc. | 4 | $71 |
| Nalpropion Pharmaceuticals LLC | 3 | $49 |
| Antares Pharma, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Vivus LLC | 1 | $16 |
| Senseonics, Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$230,934
- DEXCOM G6 TRANSMITTER$15,161
- TRULICITY$14,663
- INVOKANA$7,708
- DEXCOM G6 CGM SYSTEM$2,654
- DEXCOM CGM$2,397
- ZEPBOUND$2,025
- FARXIGA$125
- EVENITY$115
- Synthroid$110
How this compares
$295,868 in reported general payments places this provider in the 95th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in Long Beach
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
- Daniel Einhornla Jolla$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.